Skip to main content
XXII
NASDAQ Manufacturing

22nd Century Group Q2 2026: Revenue Down 30%, Going Concern Doubt, Warrant Overhang

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
8
Price
$4.325
Mkt Cap
$1.493M
52W Low
$3.61
52W High
$741.48
52W Position info
20% above low
Off High info
99% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

XXII sits 20% above its 52-week low of $3.61.

Summary

22nd Century Group's Q2 2026 10-Q confirms a 30% revenue decline, reiterates going concern doubt, and discloses a warrant amendment that could massively dilute shareholders.


Key Events · Earnings and Guidance · XXII

  • Revenue Decline Confirmed

    Q2 2026 revenue fell 29.9% to $2.86M from $4.08M a year ago, driven by a strategic shift away from low-priced CMO export customers.

  • Going Concern Doubt Reiterated

    The company states substantial doubt about its ability to continue as a going concern, with cash of $6.06M and an accumulated deficit of $405.5M as of June 30, 2026.

  • Warrant Amendment and Cashless Exercise

    On August 13, 2026, the exercise price of 3.02M June 2026 Inducement Warrants was reduced to $0.3675, and all warrants were exercised cashlessly for 2.74M shares, with 2.53M shares held in abeyance.

  • Smoker Friendly Termination

    Smoker Friendly provided a 180-day termination notice effective July 1, 2026, which will result in a $300K impairment charge in Q3 2026 related to a predicate license intangible asset.


Analysis · XXII · Manufacturing

The 10-Q confirms the Q2 revenue decline already previewed in the 8-K, but adds critical context: substantial doubt about the company's ability to continue as a going concern, with only $6.1M in cash and a $405.5M accumulated deficit. The filing also reveals a subsequent warrant amendment that reduced the exercise price to $0.3675 and triggered cashless exercise of 3.02M warrants, creating massive potential dilution. The termination of the Smoker Friendly agreement will add a $300K impairment charge in Q3.

At the time of this filing, XXII was trading at $4.33 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $3.61 to $741.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Aug 14, 2026, 4:13 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $4.33 info
Change: $0 (0%) info
Market Cap: $1.493M info
XXII
Aug 13, 2026, 6:14 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $4.33 info
Change: +$0.1388 (+3%) info
Market Cap: $1.493M info
XXII
Aug 13, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $4.33 info
Change: +$0.1388 (+3%) info
Market Cap: $1.493M info
XXII
Jul 02, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.01
Real-time Price: $4.33 info
Change: +$0.315 (+8%) info
Market Cap: $1.493M info
XXII
Jun 26, 2026, 4:15 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $3.93
Real-time Price: $4.33 info
Change: +$0.395 (+10%) info
Market Cap: $1.493M info